HEALTHCARE & MEDICARE
-
Roche's metabolic drug strategy is available at $89BIO acquisition for extended to liver disease pounding
There are two FDA-approved drugs for metabolizing diseases, called MASH. Roche paid $2.4 billion to buy 89BIO and its later…
Read More » -
Why insurance companies need to lead healthcare consumerism
Healthcare consumerism is the idea that individuals have the right to make informed choices about their care and coverage. It…
Read More » -
Behind the “Malicious Rise” in ER Psychiatry: Why Better Patient Classification Is Important
As more and more patients are used for mental health care in our country’s already oversubscribed emergency departments (EDS), Mental…
Read More » -
LōvuHealth Rakes on $8 million maternal health platform
The company announced last week that digital maternal health company LōvuHealth has received $8 million in Series A funding, which…
Read More » -
Commemorate National HIV/AIDS Aging Day
On September 18, we acknowledge National HIV/AIDS Aging Awareness Day. This observation respects the history of radicalism and medical advances,…
Read More » -
GSK plans to spend $30B over the next 5 years on U.S. manufacturing and R&D infrastructure
In his second visit, Gsk said the UK said in his second state visit that it would spend $30 billion…
Read More » -
Delegation Dilemma: Why It's Time to Have a Health Plan Reconsider Utilization Management
Delegating Utilization Management (UM) functions to third-party suppliers over the years was a practical response to rising healthcare costs, regulatory…
Read More » -
Solve the primary care crisis by integrating advanced practice providers (APPs)
The primary care physician (PCP) shortage is in a crisis proportion and is expected to continue to be an industry-wide…
Read More » -
Harbor Health secures $130 million to develop insurance plans and clinical footprint
Primary and professional nursing clinics and insurer Harbor Health announced last week that it raised $130 million in funding. Financing…
Read More » -
Picking up drugs from Sanofi, startup Allrock targets two serious lung diseases
The goals of the Allrock Bio study have been validated by FDA-approved drugs. The Biotech startup expands science to the…
Read More »